Title:
運動障害の処置のためのＰＤＥ７インヒビターの使用
Document Type and Number:
Japanese Patent JP5580192
Kind Code:
B2
Abstract:
A method of treating a movement abnormality associated with the pathology of a neurological movement disorder, such as Parkinson's disease or Restless Leg(s) Syndrome by administering a therapeutically effective amount of a PDE7 inhibitory agent. An aspect of the invention provides for the administration of a PDE& inhibitory agent in conjunction with a dopamine agonist or precursor, such as levodopa. In another aspect of the invention, the PDE7 inhibitory agent may be selective for PDE7 relative to other molecular targets (i) known to be involved with the pathology of Parkinson's disease or (ii) at which other drug(s) that are therapeutically effective to treat Parkinson's disease act.
Inventors:
Bergman and John E.
Katt Sal and Neal S.
デモプーロス and Gregory Ey.
Florio and Vincent Ey.
ゲイタ naris and George
Gray and Patrick
Hoffmann and John
The on-last and Rene
Tseng and ホンクイ
Katt Sal and Neal S.
デモプーロス and Gregory Ey.
Florio and Vincent Ey.
ゲイタ naris and George
Gray and Patrick
Hoffmann and John
The on-last and Rene
Tseng and ホンクイ
Application Number:
JP2010501232A
Publication Date:
August 27, 2014
Filing Date:
March 27, 2008
Export Citation:
Assignee:
Homet Ross Corporation
International Classes:
A61K31/519; A61K31/10; A61K31/195; A61K31/198; A61K31/4162; A61K31/4168; A61K31/433; A61K31/435; A61K31/495; A61K31/527; A61K31/53; A61K45/00; A61P25/14; A61P25/16; A61P43/00; C07D239/70; C07D285/12; C07D285/135; C07D487/04
Attorney, Agent or Firm:
Shusaku Yamamoto
Natsuki Morishita
Natsuki Morishita